NUTRA PHARMA CORP
AI Executive Summary
AI-powered analysis of 10-Q filing content
Nutra Pharma Corp exhibits severe financial distress with stockholders' deficit of $17.3 million and current liabilities of $17.7 million against only $21,844 in cash. The company's accumulated deficit increased by $459,675 in Q1 2026, indicating continued operating losses. Total liabilities exceed total assets by nearly 30x the available cash position.
Red Flags Detected (7)
Stockholders' deficit of $17.3 million indicates technically insolvent position
Current liabilities of $17.7 million vs cash of only $21,844 - severe liquidity crisis
Accumulated deficit increased by $459,675 to $78.7 million in Q1 2026
4 more red flags detected
Key Takeaways
Company appears to be in severe financial distress with negative equity
Liquidity crisis evident with massive current liability burden vs minimal cash
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.